COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,252 Articles (22,733 medRxiv, 8,519 bioRxiv)

Most recent first Previous |  Page 659: Articles 6581-6590  | Next

Rates of COVID-19-Associated Hospitalization in Immunocompromised Individuals in Omicron-era: A Population-Based Observational Study Using Surveillance Data in British Columbia, Canada
Bahremand, T., Yao, J. A., Mill, C., Piszczek, J., Grant, J. M., Smolina, K.
10.1101/2022.08.22.22278955 — Posted: 2022-08-23
Nation-wide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study
Olesen, T. B., Jensen, H., Moller, H., Jensen, J. W., Andersen, B., Rasmussen, M.
10.1101/2022.08.18.22278786 — Posted: 2022-08-23
Participation in the nation-wide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study
Olesen, T. B., Jensen, H., Moeller, H., Jensen, J. W., Waldstroem, M., Andersen, B.
10.1101/2022.08.17.22278655 — Posted: 2022-08-23
Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi
Mseka, U. L., Mandolo, J., Nyoni, K., Divala, O., Kambalame, D., Mapemba, D., Kamzati, M., Chibwe, I., Henrion, M. Y. R., Manda, K., Thindwa, D., Mvula, M., Odala, B., Kamng'ona, R., Dzinza, N., Jere, K. C., Feasey, N., Ho, A., Amoah, A. S., Gordon, M., Swarthout, T. D., Crampin, A., Heyderman, R. S., Kagoli, M., Chitsa-Banda, E., Mitambo, C., Phuka, J., Chilima, B., Kasambara, W., Jambo, K. C., Chauma-Mwale, A.
10.1101/2022.08.22.22279060 — Posted: 2022-08-23
Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
Kaufman, H. W., Meyer, W. A., Clarke, N. J., Meyer, W. A., Rank, C. M., Freeman, J., Eisenberg, M., Gillim, L., Morice, W. G., Briscoe, D. M., Perlin, D. S., Wohlgemuth, J. G.
10.1101/2022.08.22.22279079 — Posted: 2022-08-23
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Melo-Gonzalez, F., Mendez, C., Penaloza, H. F., Schultz, B. M., Pina-Iturbe, A., Rios, M., Moreno-Tapia, D., Pereira-Sanchez, P., Leighton, D., Orellana, C., Covarrubias, C., Galvez, N. M., Soto, J. A., DUARTE, L. F., Rivera-Perez, D., Vazquez, Y., Cabrera, A., Bustos, S., Iturriaga, C., Urzua, M., Navarrete, M. S., Rojas, A., Fasce, R., Fernandez, J., Mora, J., Ramirez, E., Gaete-Argel, A., Acevedo, M., Valiente-Echeverria, F., Soto-Rifo, R., Weiskopf, D., Grifoni, A., Sette, A., Zeng, G., Meng, W., CoronaVac03CL Study Group, , Gonzalez-Aramundiz, J. V., Gonzalez, P. A., Abarca, K., Bueno, S. M., Kalergis, A. M.
10.1101/2022.08.22.22279080 — Posted: 2022-08-23
RNA polymerase inhibitor enisamium for treatment of moderate COVID-19 patients: a randomized, placebo-controlled, multicenter, double-blind phase 3 clinical trial
Holubovska, O., Babich, P., Mironenko, A., Milde, J., Lebed, Y., Stammer, H., Mueller, L., te Velthuis, A. J. W., margitich, V., Goy, A.
10.1101/2022.08.21.22279036 — Posted: 2022-08-23
The butterfly effect: mutational bias of SARS-CoV-2 affects its pattern of molecular evolution on synonymous and nonsynonymous levels
Voronka, A., Efimenko, B., Oreshkov, S., Franco, M., Fleischmann, Z., Yurov, V., Trufanova, A., Timonina, V., Ree, N., Penfrat, E., Junier, T., Agranovsky, A., Khrapko, K., Gunbin, K., Fellay, J., Popadin, K.
10.1101/2022.08.22.504819 — Posted: 2022-08-22
Neutrophil proteomics identifies temporal changes and hallmarks of delayed recovery in COVID19
Long, M. B., Howden, A. J., Keir, H. R., Rollings, C. M., Giam, Y. H., Pembridge, T., Abo-Leyah, H., Lloyd, A., Sollberger, G., Hull, R., Gilmour, A., Hughes, C., New, B. J., Cassidy, D., Shoemark, A., Richardson, H., Lamond, A. I., Cantrell, D., Chalmers, J., Brenes, A. J.
10.1101/2022.08.21.22279031 — Posted: 2022-08-22
A pilot study of 0.4% povidone-iodine nasal spray to eradicate SARS-CoV-2 in the nasopharynx
Sirijatuphat, R., Leelarasamee, A., Puangpet, T., Thitithanyanont, A.
10.1101/2022.08.18.22278340 — Posted: 2022-08-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).